Just about a year ago, the U.S. Food and Drug Administration approved Novo Nordisk’s blockbuster obesity drug, Wegovy, for use in teens ages 12 and up with a BMI at or above the 95th percentile for ...
In a late-stage clinical trial, a drug similar to Ozempic was shown to reduce body mass index in kids ages 6 to 11 with obesity, according to results published Tuesday in the New England Journal of ...
A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study shows. Liraglutide lowered body mass, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback